Gossamer Bio Future Growth
Future criteria checks 1/6
Gossamer Bio is forecast to grow earnings and revenue by 23.2% and 18.2% per annum respectively while EPS is expected to grow by 29.1% per annum.
Key information
23.2%
Earnings growth rate
29.1%
EPS growth rate
| Biotechs earnings growth | 28.8% |
| Revenue growth rate | 18.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 17 Sep 2024 |
Recent future growth updates
Recent updates
Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss
Sep 10Brokers Are Upgrading Their Views On Gossamer Bio, Inc. (NASDAQ:GOSS) With These New Forecasts
Aug 14
Peaking Back In On Gossamer Bio
Sep 27Gossamer Bio to raise $120M in a private equity placement
Jul 13Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?
Jun 25Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?
Jan 19Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?
Sep 22Need To Know: Gossamer Bio, Inc. (NASDAQ:GOSS) Insiders Have Been Buying Shares
Jan 28Gossamer Bio (GOSS) Investor Presentation - Slideshow
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 63 | -122 | -14 | -12 | 8 |
| 12/31/2025 | 19 | -177 | -99 | -97 | 8 |
| 12/31/2024 | 111 | -68 | 0 | 0 | 8 |
| 6/30/2024 | 96 | -81 | -4 | -4 | N/A |
| 3/31/2024 | N/A | -173 | -158 | -158 | N/A |
| 12/31/2023 | N/A | -180 | -159 | -159 | N/A |
| 9/30/2023 | N/A | -187 | -174 | -173 | N/A |
| 6/30/2023 | N/A | -207 | -176 | -176 | N/A |
| 3/31/2023 | N/A | -221 | -187 | -187 | N/A |
| 12/31/2022 | N/A | -229 | -188 | -187 | N/A |
| 9/30/2022 | N/A | -230 | -180 | -180 | N/A |
| 6/30/2022 | N/A | -231 | -186 | -185 | N/A |
| 3/31/2022 | N/A | -234 | -184 | -183 | N/A |
| 12/31/2021 | N/A | -234 | -191 | -189 | N/A |
| 9/30/2021 | N/A | -242 | -192 | -185 | N/A |
| 6/30/2021 | N/A | -240 | -195 | -188 | N/A |
| 3/31/2021 | N/A | -247 | -205 | -183 | N/A |
| 12/31/2020 | N/A | -243 | -201 | -176 | N/A |
| 9/30/2020 | N/A | -233 | -205 | -184 | N/A |
| 6/30/2020 | N/A | -224 | -197 | -175 | N/A |
| 3/31/2020 | N/A | -202 | -178 | -169 | N/A |
| 12/31/2019 | N/A | -180 | -151 | -145 | N/A |
| 9/30/2019 | N/A | -164 | -130 | -126 | N/A |
| 6/30/2019 | N/A | -165 | -119 | -105 | N/A |
| 3/31/2019 | N/A | -154 | -108 | -75 | N/A |
| 12/31/2018 | N/A | -147 | -72 | -51 | N/A |
| 9/30/2018 | N/A | -115 | -53 | -32 | N/A |
| 6/30/2018 | N/A | -66 | -27 | -16 | N/A |
| 3/31/2018 | N/A | -33 | N/A | -9 | N/A |
| 12/31/2017 | N/A | -7 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GOSS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GOSS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GOSS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: GOSS's revenue (18.2% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: GOSS's revenue (18.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GOSS's Return on Equity is forecast to be high in 3 years time